250 related articles for article (PubMed ID: 28785798)
1. High prevalence of neuronal surface autoantibodies associated with cognitive deficits in cancer patients.
Finke C; Bartels F; Lütt A; Prüss H; Harms L
J Neurol; 2017 Sep; 264(9):1968-1977. PubMed ID: 28785798
[TBL] [Abstract][Full Text] [Related]
2. Neuronal autoantibodies associated with cognitive impairment in melanoma patients.
Bartels F; Strönisch T; Farmer K; Rentzsch K; Kiecker F; Finke C
Ann Oncol; 2019 May; 30(5):823-829. PubMed ID: 30840061
[TBL] [Abstract][Full Text] [Related]
3. Paraneoplastic cerebellar syndromes associated with antibodies against Purkinje cells.
Schwenkenbecher P; Chacko L; Pul R; Sühs KW; Wegner F; Wurster U; Stangel M; Skripuletz T
Int J Neurosci; 2018 Aug; 128(8):721-728. PubMed ID: 29199513
[TBL] [Abstract][Full Text] [Related]
4. A large screen for paraneoplastic neurological autoantibodies; diagnosis and predictive values.
Seluk L; Taliansky A; Yonath H; Gilburd B; Amital H; Shoenfeld Y; Kivity S
Clin Immunol; 2019 Feb; 199():29-36. PubMed ID: 30543927
[TBL] [Abstract][Full Text] [Related]
5. Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis.
Bien CG; Vincent A; Barnett MH; Becker AJ; Blümcke I; Graus F; Jellinger KA; Reuss DE; Ribalta T; Schlegel J; Sutton I; Lassmann H; Bauer J
Brain; 2012 May; 135(Pt 5):1622-38. PubMed ID: 22539258
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of IgM and IgA class anti-NMDAR antibodies in herpes simplex encephalitis.
Westman G; Sohrabian A; Aurelius E; Ahlm C; Schliamser S; Sund F; Studahl M; Rönnelid J
J Clin Virol; 2018 Jun; 103():75-80. PubMed ID: 29698873
[TBL] [Abstract][Full Text] [Related]
7. Neuronal antibodies in pediatric epilepsy: Clinical features and long-term outcomes of a historical cohort not treated with immunotherapy.
Wright S; Geerts AT; Jol-van der Zijde CM; Jacobson L; Lang B; Waters P; van Tol MJ; Stroink H; Neuteboom RF; Brouwer OF; Vincent A
Epilepsia; 2016 May; 57(5):823-31. PubMed ID: 26996997
[TBL] [Abstract][Full Text] [Related]
8. Paraneoplastic Neurological Syndromes and Glutamic Acid Decarboxylase Antibodies.
Ariño H; Höftberger R; Gresa-Arribas N; Martínez-Hernández E; Armangue T; Kruer MC; Arpa J; Domingo J; Rojc B; Bataller L; Saiz A; Dalmau J; Graus F
JAMA Neurol; 2015 Aug; 72(8):874-81. PubMed ID: 26099072
[TBL] [Abstract][Full Text] [Related]
9. Clinical and Immunological Features of Opsoclonus-Myoclonus Syndrome in the Era of Neuronal Cell Surface Antibodies.
Armangué T; Sabater L; Torres-Vega E; Martínez-Hernández E; Ariño H; Petit-Pedrol M; Planagumà J; Bataller L; Dalmau J; Graus F
JAMA Neurol; 2016 Apr; 73(4):417-24. PubMed ID: 26856612
[TBL] [Abstract][Full Text] [Related]
10. [Paraneoplastic neurological syndromes with reference to anti-neuronal autoantibodies].
Tanaka K
Rinsho Shinkeigaku; 2010 Jun; 50(6):371-8. PubMed ID: 20593661
[TBL] [Abstract][Full Text] [Related]
11. Dysfunction of the blood-cerebrospinal fluid-barrier and N-methyl-D-aspartate glutamate receptor antibodies in dementias.
Busse M; Kunschmann R; Dobrowolny H; Hoffmann J; Bogerts B; Steiner J; Frodl T; Busse S
Eur Arch Psychiatry Clin Neurosci; 2018 Aug; 268(5):483-492. PubMed ID: 28176002
[TBL] [Abstract][Full Text] [Related]
12. [Anti-Ma2-associated encephalitis and paraneoplastic limbic encephalitis].
Yamamoto T; Tsuji S
Brain Nerve; 2010 Aug; 62(8):838-51. PubMed ID: 20714032
[TBL] [Abstract][Full Text] [Related]
13. Semi-quantitative analyses of antibodies to N-methyl-d-aspartate type glutamate receptor subunits (GluN2B & GluN1) in the clinical course of Rasmussen syndrome.
Fukuyama T; Takahashi Y; Kubota Y; Mogami Y; Imai K; Kondo Y; Sakuma H; Tominaga K; Oguni H; Nishimura S
Epilepsy Res; 2015 Jul; 113():34-43. PubMed ID: 25986190
[TBL] [Abstract][Full Text] [Related]
14. Anti-Neuronal Autoantibodies in Both Drug Responsive and Resistant Focal Seizures with Unknown Cause.
Gozubatik-Celik G; Ozkara C; Ulusoy C; Gunduz A; Delil S; Yeni N; Tuzun E
Epilepsy Res; 2017 Sep; 135():131-136. PubMed ID: 28675819
[TBL] [Abstract][Full Text] [Related]
15. [Limbic encephalitis: the new cell membrane antigens and a proposal of clinical-immunological classification with therapeutic implications].
Dalmau J; Bataller L
Neurologia; 2007 Oct; 22(8):526-37. PubMed ID: 18000762
[TBL] [Abstract][Full Text] [Related]
16. Significance of Autoantibodies in Autoimmune Encephalitis in Relation to Antigen Localization: An Outline of Frequently Reported Autoantibodies with a Non-Systematic Review.
Tanaka K; Kawamura M; Sakimura K; Kato N
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32668637
[TBL] [Abstract][Full Text] [Related]
17. Seroprevalence survey of selective anti-neuronal autoantibodies in patients with first-episode schizophrenia and chronic schizophrenia.
Chen CH; Cheng MC; Liu CM; Liu CC; Lin KH; Hwu HG
Schizophr Res; 2017 Dec; 190():28-31. PubMed ID: 28341002
[TBL] [Abstract][Full Text] [Related]
18. Anti-neuronal anti-bodies in patients with early psychosis.
Mantere O; Saarela M; Kieseppä T; Raij T; Mäntylä T; Lindgren M; Rikandi E; Stoecker W; Teegen B; Suvisaari J
Schizophr Res; 2018 Feb; 192():404-407. PubMed ID: 28461116
[TBL] [Abstract][Full Text] [Related]
19. Seroprevalence of N-methyl-D-aspartate glutamate receptor (NMDA-R) autoantibodies in aging subjects without neuropsychiatric disorders and in dementia patients.
Busse S; Busse M; Brix B; Probst C; Genz A; Bogerts B; Stoecker W; Steiner J
Eur Arch Psychiatry Clin Neurosci; 2014 Sep; 264(6):545-50. PubMed ID: 24604707
[TBL] [Abstract][Full Text] [Related]
20. Association Between Neuronal Autoantibodies and Cognitive Impairment in Patients With Lung Cancer.
Bartels F; Wandrey MM; Aigner A; Strönisch T; Farmer K; Rentzsch K; Tessmer A; Grohé C; Finke C
JAMA Oncol; 2021 Sep; 7(9):1302-1310. PubMed ID: 34196651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
